Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606
- Registration Number
- NCT00757341
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Brief Summary
This study will assess the mass balance, metabolic disposition, and identification of metabolites following single oral administration of \[14C\]-SKI-606 in healthy male subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description SKI-606 SKI-606 -
- Primary Outcome Measures
Name Time Method Mass Balance and Metabolic Disposition 10 days
- Secondary Outcome Measures
Name Time Method